Oppenheimer Reiterates Perform Rating on Nordson (NDSN)

Go back to Oppenheimer Reiterates Perform Rating on Nordson (NDSN)

Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies

May 28, 2024 7:00 AM EDT

Expands Nordson MEDICALs total addressable market Highly complementary with Nordsons customer base and core competencies Broadens Nordsons exposure to higher-growth and stable medical end markets Nordson to host investor call at 8:30 a.m. ET today

WESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for... More